Status:
UNKNOWN
Patterns of Breast Cancer Management and Prognosis of Breast Cancer in China
Lead Sponsor:
Fengxi Su
Conditions:
Breast Cancer
Eligibility:
All Genders
Brief Summary
This is a multicenter, prospective, e, real-world cohort survey initiated by researchers to focus on the patterns of breast cancer management and prognosis of breast cancer in China, and to establish ...
Eligibility Criteria
Inclusion
- Patients who are hospitalized and treated in a collaborative network unit
- Agree to enroll in the study and sign the informed consent form
- Histological diagnosis of ductal carcinoma in situ or invasive breast cancer
- Accept the Surgery-based surgical treatment
- Willing to cooperate with follow-up work
Exclusion
- Previously Excisional biopsy (including minimally invasive resection) of the patient's breast
- Previously received neoadjuvant chemotherapy
- Imaging or histological evidence of distant metastasis
Key Trial Info
Start Date :
September 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT04076111
Start Date
September 5 2019
End Date
December 1 2025
Last Update
September 3 2019
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Province Hospital of Chinese Medicine
Guangzhou, Guangdong, China, 510000
2
Sun Yat-sen Memorial Hospital,Sun Yat-sen University
Guangzhou, Guangdong, China, 510000
3
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China, 510000
4
Cancer Hospital OF Shantou University Medical College
Shantou, Guangdong, China, 515000